WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. ("Eagle") (Nasdaq:EGRX) today announced that
the Company will release its 2014 second quarter financial results on
Wednesday, May 14, 2014, before the market opens.

Following release of the results, the Company will host a conference
call at 9:30 a.m. Eastern Daylight Time. Scott Tarriff, President and
Chief Executive Officer, and David E. Riggs, Chief Financial Officer,
will conduct the call.

Interested parties may participate in the conference call by dialing
866-952-1906 (US), or 785-424-1825 (International), 5-10 minutes prior
to the start of the call. A replay of the conference call will be
available for two weeks after the call's completion by dialing
866-952-1906 (US) or 785-424-1825 (International) and entering
conference call ID number EGRXQ214.

A live audio webcast and archive will also be available for 30 days
under the “Investor Relations” section of the Eagle website at www.eagleus.com.

ABOUT EAGLE

Eagle is a specialty pharmaceutical company focused on developing and
commercializing injectable products utilizing the FDA's 505(b)(2)
regulatory pathway. The Company develops products that address the
shortcomings, as identified by physicians, pharmacists and other
stakeholders, of existing commercially successful injectable products.
Additional information is available on the company’s website at
eagleus.com.